Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences [Yahoo! Finance]
Quanterix Corporation (QTRX)
US:NASDAQ Investor Relations:
ir.quanterix.com/investor-relations
Company Research
Source: Yahoo! Finance
1.5% of the outstanding common shares of Quanterix Corp. ("Quanterix" or the "Company") (Nasdaq: QTRX), today issued a statement calling on the Company to explain its most recent purchase agreement for up to $30 million in convertible notes from Akoya Biosciences, Inc. ("Akoya") (Nasdaq: AKYA). Tikvah's statement follows: "This announcement concerns us for several reasons. First, we believe Akoya's need to obtain bridge financing serves as a significant warning sign of its financial distress. Second, we find it both unusual and coercive to Quanterix's shareholders that this capital is being committed before a shareholder vote on the Company's proposed merger with Akoya. Lastly, the terms of these convertible notes are significantly off market and unfair to Quanterix shareholders. Quanterix owes shareholders an explanation as to why it has put its investors in such a seemingly disadvantaged position." Tikvah reiterates its previous statement and continues to plan to vote AGAINST
Show less
Read more
Impact Snapshot
Event Time:
QTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTRX alerts
High impacting Quanterix Corporation news events
Weekly update
A roundup of the hottest topics
QTRX
News
- Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth [Yahoo! Finance]Yahoo! Finance
- Quanterix Announces Board and Leadership Changes to Support Next Stage of GrowthBusiness Wire
- Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring [Yahoo! Finance]Yahoo! Finance
- Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis MonitoringBusiness Wire
- Alzheimer Biomarker Based Diagnostic Research Report 2025-2035: Market to Transform with Rise of Blood-Based Tests, Emerging as a Less Invasive and Scalable Alternative to CSF and PET Methods [Yahoo! Finance]Yahoo! Finance
QTRX
Earnings
- 11/10/25 - Miss
QTRX
Sec Filings
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- 12/8/25 - Form 4
- QTRX's page on the SEC website